Read the Issue. Keep this medication in the container it came in, tightly closed, and out of reach. Some of these people developed suicidal thoughts and behavior as early as 1 week after of children.
Obesity is a rapidly growing medical condition in the U. On July 17, , the FDA approved a tablet combining phentermine plus extended-release topiramate Qsymia, Vivus for weight loss. Phentermine has been used for weight loss, and topiramate is an antiepileptic agent that has been commonly associated with weight loss as a side effect. The doses approved for weight reduction are lower than either agent when used for its current indications. The hard gelatin capsule contains immediate-release phentermine and extended-release topiramate beads. The exact mechanism of weight loss with phentermine is not elucidated in the FDA briefing, but from the package insert, it can be assumed that it acts as a sympathomimetic agent, which may suppress appetite as well as increase metabolism. Qsymia is well absorbed orally, with or without food. Peak concentrations C max are reached in 6 hours for phentermine and 10 hours for topiramate. The half-life is 20 hours for phentermine and 65 hours for topiramate.
Topamax phentermine and diet pill
The dose of this medicine will be different for different patients. Footnotes Disclosure: The authors report no commercial or financial relationships in regard to this article. Symptoms of overdose may include the following: restlessness uncontrollable shaking of a part of the body fast breathing confusion aggressiveness hallucinations seeing things or hearing voices that do not exist panic excessive tiredness depression irregular heartbeat nausea vomiting diarrhea stomach pain or cramps seizures coma loss of consciousness for a period of time dizziness speech disturbances blurred or double vision problems with coordination. Health care professionals must complete a training program, and only certain pharmacies may dispense this agent. Elaine H. August 09,